Your search returned 124 results. Subscribe to this search

|
1. Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology

by Van Nostrand, Douglas.

Published: ; 2020Citation: Head & Neck. 2020 Aug 19.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Singer MC; Marchal F; Angelos P; Bernet V; Boucai L; Buchholzer S; Burkey B; Eisele D; Erkul E; Faure F; Freitag SK; Gillespie MB; Harrell RM; Hartl D; Haymart M; Leffert J; Mandel S; Miller BS; Morris J; Pearce EN; Rahmati R; Ryan WR; Schaitkin B; Schlumberger M; Stack BC; Van Nostrand D; Wong KK; Randolph G.UI/PMID: 32812307.Digital Object Identifier: https://dx.doi.org/10.1002/hed.26417 (Click here)
2. David C. Moses, MD (1940-2020)

by Van Nostrand, Douglas.

Published: ; 2020Citation: Journal of Nuclear Medicine. 61(6):20N, 2020 Jun..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Van Nostrand D.UI/PMID: 32499287.Online Access: Click here to access online
3. The Martinique Principles

by Van Nostrand, Douglas.

Published: ; 2019Citation: Journal of Nuclear Medicine. 60(9):1334-1335, 2019 09..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Letter.Full author list: Ahuja S; Avram AM; Dillehay G; Greenspan BS; Gulec S; Van Nostrand D.UI/PMID: 31227575.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.2967/jnumed.119.232066 (Click here)
4. Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen

by Klubo-Gwiezdzinska, Joanna; Burman, Kenneth D; Van Nostrand, Douglas; Wartofsky, Leonard.

Published: ; 2011Citation: Journal of Thyroid Research. 2011:843591, 2011..Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Wartofsky L.UI/PMID: 21876837.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.4061/2011/843591 (Click here)
5. Brief progress report from the intersocietal working group on differentiated thyroid cancer

by Van Nostrand, Douglas.

Published: ; 2020Citation: European Journal of Nuclear Medicine & Molecular Imaging. 2020 Mar 12.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Editorial.Full author list: Verburg FA; Ahuja S; Avram AM; Bardies M; Bernet V; Bourguet P; Fuhrer-Sakel D; Draganescu C; Daniels GH; Greenspan B; Gulec S; Hegedus L; Jonklaas J; Luster M; Oyen W; Smit J; Tuttle RM; Zerdoud S; Van Nostrand D.UI/PMID: 32166513.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1007/s00259-020-04744-8 (Click here)
6. Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade

by Van Nostrand, Douglas.

Published: 2019; Citation: European Journal of Nuclear Medicine & Molecular Imaging. 2019 Oct 15.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Flux G; Giovanella L; Luster M; Muylle K; van Nostrand D; Verburg FA.UI/PMID: 31616967.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1007/s00259-019-04479-1 (Click here)
7. Nationwide survey of implementation of 2011 Nuclear Regulatory Commission policy on release of patients after 131I therapy

by Wu, Di; Gomes-Lima, Cristiane J; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: ; 2019Citation: Journal of Nuclear Medicine. 2019 Aug 26.Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Wu D; Gomes-Lima CJ; Bloom G; Burman KD; Wartofsky L; Van Nostrand D.UI/PMID: 31451488.Digital Object Identifier: https://dx.doi.org/10.2967/jnumed.119.230730 (Click here)
8. I-124 PET/CT versus conventional radioiodine imaging in differentiated thyroid cancer: a review

by Wu, Di; Ylli, Dorina; Heimlich, S Layla; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: ; 2019Citation: Thyroid. 2019 Aug 27.Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Library; Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Wu D; Ylli D; Heimlich SL; Burman KD; Wartofsky L; Van Nostrand D.UI/PMID: 31452449.Digital Object Identifier: https://dx.doi.org/10.1089/thy.2018.0598 (Click here)
9. Poor compliance for continuous sialogogues in patient-reported surveys

by Wu, Di; Moreau, Shari; Kulkarni, Kanchan P; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Citation: 2018/04/30/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Khorjekar G; Kharazi P; Moreau S; Kulkarni K; Burman K; Wartofsky L; Van Nostrand D. .Local accession number: B2018215.
10. Evaluation of the relationship of reproductive hormones to radioiodine breast uptake in patients with differentiated thyroid cancer: a pilot study

by Kulkarni, Kanchan P; Kumar, Anagha; Wu, Di; Van Nostrand, Douglas.

Published: 2018Citation: 2018/04/30/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Kulkarni K; Kumar A; Wu D; Van Nostrand D. .Local accession number: B201870.
11. Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer

by Wu, Di; Van Nostrand, Douglas.

Published: 2018Citation: 2018/04/30/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Plyku D; Wu D; Byard J; Brown T; Hobbs R; Sgouros G; Van Nostrand D. .Local accession number: B201872.
12. New use for an old isotope

by Wu, Di; Ylli, Dorina; Gomes Lima, Christiane J; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Citation: 2018/04/30/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Ylli D; Gomes Lima C; Burman K; Wartofsky L; Van Nostrand D. .Local accession number: B201874.
13. Prevalence and survival analysis of patients with brain metastases from differentiated thyroid carcinoma in MedStar institutions

by Gomes Lima, Christiane J; Wu, Di; Punukollu, Sree; Hritani, Rama; Rao, Sarika; Zeymo, Alexander; Deeb, Hala; Mete, Mihriye; Aulisi, Edward; Van Nostrand, Douglas; Burman, Kenneth D.

Published: 2018Citation: 2018/04/30/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Surgery/Neurosurgery.Publication: Poster Presentation.Full author list: Gomes-Lima C; Wu D; Punukollu S; Hritani R; Rao S; Zeymo A; Deeb H; Mete M; Aulisi E; Van Nostrand D; Jonklaas J; Burman K. .Local accession number: B201879.
14. Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer

by Wu, Di; Kulkarni, Kanchan P; Garcia, Carlos A; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Citation: 2018/04/30/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Kulkarni K; Garcia C; Burman K; Wartofsky L; Van Nostrand D. .Local accession number: B201889.
15. The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: a systematic review and meta-analysis

by Wu, Di; Heimlich, Layla; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Citation: 2018/04/30/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Library; Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Heimlich SL; Burman K; Wartofsky L; Van Nostrand D. .Local accession number: B201890.
16. Radioiodine treatment of metastatic thyroid cancer: progression free survival is similar for patients with distant metastases prepared with recombinant human tsh or with thyroid hormone withdrawal

by Gomes Lima, Christiane J; Chittimoju, Sanjita; Jat, Sunita; Pagadala, Prathyusha; Jhawar, Sakshi; Al-Jundi, Mohammad; Van Nostrand, Douglas; Wartofsky, Leonard; Burman, Kenneth D.

Published: 2018Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: ENDO 2018, ; Gomes-Lima CJ; Chittimoju S; Wehbeh L; Jat SK; Pagadala P; Jhawar S; Al-Jundi MN; Zeymo A; Mete M; Klubo-Gwiezdzinska J; Jonklaas J; Van Nostrand D; Wartofsky L; Burman KD.Local accession number: B2018452.
17. Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer

by Wu, Di; Brown, Taneshea A; Van Nostrand, Douglas.

Published: 2018Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Plyku D; Wu D; Byard J; Brown TA; Hobbs R; Sgouros G; Van Nostrand D..Local accession number: B2018454.
18. New use for an old isotope

by Wu, Di; Ylli, Dorina; Gomes Lima, Christiane J; Lee W; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman K; Wartofsky L; Van Nostrand D. .Local accession number: B2018455.
19. Nationwide survey on the changes in release of I-131 therapy patients after the implementation of the 2011 NRC regulatory policy

by Wu, Di; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: ; Wu D; Bloom G; Burman KD; Wartofsky L; Van Nostrand D. .Local accession number: B2018640.
20. The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: systematic review and meta-analysis

by Wu, Di; Heimlich, Layla; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Wu D; Heimlich L; Burman K; Wartofsky L; Van Nostrand D. .Local accession number: B2018644.
21. Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer

by Wu, Di; Kulkarni, Kanchan P; Garcia, Carlos A; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Wu D; Kulkarni K; Garcia C; Burman K; Wartofsky L; Van Nostrand D..Local accession number: B2018645.
22. Poor compliance for continuous sialogogues in patient-reported surveys

by Wu, Di; Moreau, Shari; Kulkarni, Kanchan P; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Wu D; Khorjekar G; Kharazi P; Moreau S; Kulkarni K; Burman K; Wartofsky L; Van Nostrand D..Local accession number: B2018646.
23. Enhancing techniques for radioiodine imaging of differentiated thyroid cancer

by Gomes-Lima, Christiane J; Wu, Di; Burman, Kenneth D; Van Nostrand, Douglas.

Published: 2018Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Gomes-Lima CJ; Wu D; Turner D; Burman K; Van Nostrand D. .Local accession number: B2018647.
24. Advanced differentiated thyroid cancer: when to stop radioiodine?

by Van Nostrand, Douglas.

Published: 2019; ; Citation: The Quarterly Journal of Nuclear Medicine. 63(3):267-270, 2019 Sep.; .Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Giovanella L; van Nostrand D.UI/PMID: 31271271.Digital Object Identifier: https://dx.doi.org/10.23736/S1824-4785.19.03191-1 (Click here)
25. Sites Performing Dosimetry for Selection of Activity for <sup>131</sup>I Therapy for Differentiated Thyroid Cancer

by Van Nostrand, Douglas.

Published: ; 2019Citation: Journal of Nuclear Medicine. 60(6):20N-22N, 2019 Jun..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Van Nostrand D.UI/PMID: 31160436.
26. Overview of the Martinique Meetings: What Has Been Established and Where Are We Going?

by Van Nostrand, Douglas.

Published: ; 2019Citation: Journal of Nuclear Medicine. 60(6):15N, 2019 Jun..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Greenspan BS; Ahuja S; Avram AM; Gulec S; Van Nostrand D.UI/PMID: 31160431.
27. Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images Are Performed Equally

by Van Nostrand, Douglas.

Published: ; 2019Citation: Thyroid. 29(7):901-909, 2019 Jul..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Van Nostrand D.UI/PMID: 31184275.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1089/thy.2018.0690 (Click here)
28. Improved Survival After Multimodal Approach with <sup>131</sup>I Treatment in Patients with Bone Metastases Secondary to Differentiated Thyroid Cancer

by Wu, Di; Gomes Lima, Cristiane J; Moreau, Shari; Kulkarni, Kanchan; Zeymo, Alexander; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: ; 2019Citation: Thyroid. 29(7):971-978, 2019 Jul..Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Wu D; Gomes Lima CJ; Moreau SL; Kulkarni K; Zeymo A; Burman KD; Wartofsky L; Van Nostrand D.UI/PMID: 31017051.Digital Object Identifier: https://dx.doi.org/10.1089/thy.2018.0582 (Click here)
29. Controversies, Consensus, and Collaboration in the Use of <sup>131</sup>I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association

by Van Nostrand, Douglas.

Published: ; 2019Citation: Thyroid. 29(4):461-470, 2019 Apr..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Tuttle RM; Ahuja S; Avram AM; Bernet VJ; Bourguet P; Daniels GH; Dillehay G; Draganescu C; Flux G; Fuhrer D; Giovanella L; Greenspan B; Luster M; Muylle K; Smit JWA; Van Nostrand D; Verburg FA; Hegedus L.UI/PMID: 30900516.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1089/thy.2018.0597 (Click here)
30. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and <sup>123</sup>I for localization of rapid washout parathyroid adenomas

by Kulkarni, Kanchan; Van Nostrand, Douglas.

Published: 2019; ; Citation: Osteoporosis International. 30(5):1051-1057, 2019 May.; .Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Kulkarni K; Kushchayev SV; Kushchayeva YS; Tella SH; Van Nostrand D.UI/PMID: 30706095.Digital Object Identifier: https://dx.doi.org/10.1007/s00198-019-04846-6 (Click here)
31. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer. [Review]

by Ylli, Dorina; Van Nostrand, Douglas; Wartofsky, Leonard.

Published: ; 2019Citation: Endocrinology & Metabolism Clinics of North America. 48(1):181-197, 2019 03..Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine; Medicine/Endocrinology.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Ylli D; Van Nostrand D; Wartofsky L.UI/PMID: 30717901.Digital Object Identifier: https://dx.doi.org/10.1016/j.ecl.2018.11.005 (Click here)
32. Brain Metastases From Differentiated Thyroid Carcinoma: Prevalence, Current Therapies, and Outcomes

by Gomes-Lima, Cristiane J; Wu, Di; Rao, Sarika N; Punukollu, Sree; Hritani, Rama; Zeymo, Alexander; Deeb, Hala; Mete, Mihriye; Aulisi, Edward; Van Nostrand, Douglas; Jonklaas, Jacqueline; Wartofsky, Leonard; Burman, Kenneth D.

Published: ; 2019Citation: Journal of the Endocrine Society. 3(2):359-371, 2019 Feb 01..Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Internal Medicine; Neurosurgery; Medicine/Nuclear Medicine; Medicine/Endocrinology.Publication: Journal Article.Article type: Journal Article.Full author list: Gomes-Lima CJ; Wu D; Rao SN; Punukollu S; Hritani R; Zeymo A; Deeb H; Mete M; Aulisi EF; Van Nostrand D; Jonklaas J; Wartofsky L; Burman KD.UI/PMID: 30706042.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1210/js.2018-00241 (Click here)
33. Detection at public facilities of <sup>131</sup>I in patients treated for differentiated thyroid cancer: the frequency, sites, management by security agents, and recommended physician documentation for patients

by Bikas, Athanasios; Wu, Di; Bethancourt, Evelyn; Orquiza, Michael; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: ; 2018Citation: Journal of Nuclear Medicine. 2018 Oct 25.Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Bikas A; Wu D; Bethancourt E; Orquiza M; Bloom G; Burman KD; Wartofsky L; Van Nostrand D.UI/PMID: 30361377.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.2967/jnumed.118.213256 (Click here)
34. Poor patient compliance with instructions for continuous sialogogues after <sup>131</sup> I therapy

by Burman, Kenneth D; Kulkarni, Kanchan; Moreau, Shari; Van Nostrand, Douglas; Wartofsky, Leonard; Wu, Di.

Published: 2019; ; ; Citation: Oral Diseases. 25(1):158-163, 2019 Jan..Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Burman KD; Kharazi P; Khorjekar G; Kulkarni K; Moreau S; Van Nostrand D; Wartofsky L; Wu D.UI/PMID: 30169900.Digital Object Identifier: https://dx.doi.org/10.1111/odi.12969 (Click here)
35. Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications

by Van Nostrand, Douglas.

Published: ; 2018Citation: Thyroid. 28(9):1083-1093, 2018 Sep..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Van Nostrand D.UI/PMID: 30105931.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1089/thy.2018.0048 (Click here)
36. I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study

by Brown, Taneshea A; Moreau, Shari; Atkins, Frank; Wu, Di; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Plyku D; Brown T; Moreau S; Atkins F; Wu D; Lodge M; Frey E; Van Nostrand D.Local accession number: A2017_428.
37. Checklist of criteria for the systematic assessment of patient-management guideline development

by Wu, Di; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Wu D; Turner D; Burman K; Wartofsky L; Van Nostrand D.Local accession number: A2017_573.
38. Radioiodine refractory differentiated thyroid cancer classifications and evolution

by Wu, Di; Gomes-Lima, Christiane J; Wartofsky, Leonard; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Wu D; Gomes-Lima CJ; Turner D; Burman K; Van Nostrand D.Local accession number: A2017_574.
39. Overall survival rate of patients with differentiated thyroid cancer bone metastasis

by Wu, Di; Gomes-Lima, Christiane J; Moreau, Shari; Kulkarni, Kanchan P; Zeymo, Alexander; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Wu D; Gomes Lima C; Moreau S; Kulkarni K; Zeymo A; Burman K; Wartofsky L; Van Nostrand D.Local accession number: A2017_575.
40. Sialoadenitis and xerostomia secondary to I-131 therapy in patients with differentiated thyroid cancer and who took sialagogues: a prospective study

by Wu, Di; Orquiza, Michael; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Wu D; Turner D; Orquiza M; Burman K; Wartofsky L; Van Nostrand D.Local accession number: A2017_576.
41. Does pretreatment with lithium prior to radioactive iodine (RAI) therapy improve outcome in patients with metastatic differentiated thyroid cancer (DTC)?

by Gomes Lima, Christiane J; Burman, Kenneth D; Van Nostrand, Douglas; Wartofsky, Leonard.

Published: 2017Citation: Unpublished 2017/04/01/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Klubo-Gwiezdzinska J; Auh S; Breymaier M; Cochran C; Gomes-Lima CJ; Van Nostrand D; Burman KD; Wartofsky L; et al. .Local accession number: A2017_312.
42. Frequency, duration and severity of salivary effects in DTC patients with onset at 7 weeks to 3 months after I-131 therapy: an analysis of the Thyca National Survey

by Mete, Mihriye; Van Nostrand, Douglas; Gomes Lima, Christiane J; Mete, Mihriye; Wu, Di.

Published: 2017Citation: Unpublished 2017/04/01/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Gomes Lima CJ; Hall JP; Khorjekar G; Brennan MT; McIver B; Mete M; Bloom G; Van Nostrand D.Local accession number: A2017_313.
43. Frequency, duration and severity of salivary side effects in DTC patients with onset at 3 to 12 months after I-131 therapy: an analysis of the Thyca National Survey

by Mete, Mihriye; Van Nostrand, Douglas; Gomes Lima, Christiane J; Mete, Mihriye; Wu, Di.

Published: 2017Citation: Unpublished 2017/04/01/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Gomes Lima CJ; Wu D; Hall JP; Khorjekar G; Brennan MT; McIver B; Mete M; Bloom G; Van Nostrand D.Local accession number: A2017_314.
44. A new method to help determine whether a +Tg/-Dx scan patient with differentiated thyroid cancer may benefit from a dosimetrically-guided I-131 therapy

by Wu, Di; Gomes-Lima, Christiane J; Kulkarni, Kanchan P; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2017Citation: Unpublished 2017/04/01/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Gomes Lima CJ; Kulkarni K; Burman K; Wartofsky L; Van Nostrand D.Local accession number: A2017_315.
45. I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study

by Van Nostrand, Douglas; Brown, Taneshea A; Moreau, Shari; Atkins, Frank; Wu, Di.

Published: 2017Citation: Unpublished 2017/05/01/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Van Nostrand D; Plyku D; Brown TA; Moreau SL; Atkins FB; Wu D; Lodge MA; Frey EC.Local accession number: A2017_004.
46. A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey

by Van Nostrand, Douglas; Wu, Di; Hall, Jordan; Khorjekar, Gauri; Zeymo, Alexander; Brennan, Michael T.

Published: 2017Citation: Unpublished 2017/05/01/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Van Nostrand D; Wu D; Hall J; Khorjekar G; Zeymo A; Brennan MT; McIver B; Bloom G.Local accession number: A2017_050.
47. Brain metastases from differentiated thyroid carcinoma: current therapies and outcomes

by Gomes-Lima, Christiane J; Wu, Di; Punukollu, Sree; Hritani, Rama; Rao, Sarika; Zeymo, Alexander; Deeb, Hala; Mete, Mihriye; Van Nostrand, Douglas; Burman, Kenneth D.

Published: 2017Citation: Unpublished 2017/10/18/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Gomes-Lima C; Wu D; Punukollu S; Hritani R; Rao S; Zeymo A; Deeb H; Mete M; Van Nostrand D; Jonklaas J; Burman K.Local accession number: A2017_568.
48. Xerophthalmia and epiphora secondary to 131I therapy in patients with differentiated thyroid cancer: a prospective study

by Wu, Di; Orquiza, Michael; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2017Citation: Unpublished 2017/10/18/.Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Turner D; Orquiza M; Burman K; Wartofsky L; Van Nostrand D.Local accession number: A2017_569.
49. Prognostic factors in the overall survival rate of patients with differentiated thyroid cancer bone metastasis

by Wu, Di; Gomes-Lima, Christiane J; Moreau, Shari; Kulkarni, Kanchan P; Zeymo, Alexander; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2017Citation: Unpublished 2017/10/18/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Gomes-Lima C; Moreau S; Kulkarni K; Zeymo A; Burman KD; Wartofsky L; Van Nostrand D.Local accession number: A2017_570.
50. Low-iodine diet and urine iodine measurements for 131-I treatments in patients with differentiated thyroid cancer: a comparison of 18 clinical practice guidelines

by Wu, Di; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2017Citation: Unpublished 2017/10/18/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Turner D; Wu D; Burman KD; Wartofsky L; Van Nostrand D.Local accession number: A2017_571.
51. Pretreatment with lithium may be associated with improved overall survival in patients undergoing dosimetry-based radioactive iodine treatment (RAI) for metastatic differentiated thyroid cancer

by Gomes-Lima, Christiane J; Van Nostrand, Douglas; Burman, Kenneth D; Wartofsky, Leonard.

Published: 2017Citation: Unpublished 2017/10/18/.Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Luo H; Tobey A; Auh S; Cochran C; Zemskova M; Gomes-Lima C; Van Nostrand D; Burman KD; Wartofsky L; et al. .Local accession number: A2017_572.
52. Overall survival rate of patients with differentiated thyroid cancer bone metastasis

by Wu, Di; Gomes-Lima, Christiane J; Moreau, Shari L; Kulkarni, Kanchan P; Zeymo, Alexander; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2017Citation: Unpublished 2017/05/01/.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Wu D; Gomes-Lima CJ; Moreau SL; Kulkarni K; Zeymo A; Burman KD; Wartofsky L; Van Nostrand D.Local accession number: A2017_074.
53. Radioiodine refractory differentiated thyroid cancer. [Review]

by Van Nostrand, Douglas.

Published: 2018Citation: Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Jin Y; Van Nostrand D; Cheng L; Liu M; Chen L.UI/PMID: 29650270.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.critrevonc.2018.03.012 (Click here)
54. Use of <sup>99m</sup>Tc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical management

by Wu, Di; Ylli, Dorina; Gomes Lima, Cristiane J; Lee, Wen; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2018Citation: Endocrine. 62(1):57-63, 2018 10..Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Pathology; Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D.UI/PMID: 29797211.Digital Object Identifier: https://dx.doi.org/10.1007/s12020-018-1636-y (Click here)
55. Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?

by Ylli, Dorina; Burman, Kenneth D; Van Nostrand, Douglas; Wartofsky, Leonard.

Published: 2018Citation: Journal of Clinical Endocrinology & Metabolism. 103(5):1813-1817, 2018 May 01..Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Ylli D; Burman KD; Van Nostrand D; Wartofsky L.UI/PMID: 29741712.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1210/jc.2017-02725 (Click here)
56. The BEIR VII Estimates of Low-Dose Radiation Health Risks Are Based on Faulty Assumptions and Data Analyses: A Call for Reassessment

by Van Nostrand, Douglas.

Published: 2018Citation: Journal of Nuclear Medicine. 59(7):1017-1019, 2018 07..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Siegel JA; Greenspan BS; Maurer AH; Taylor AT; Phillips WT; Van Nostrand D; Sacks B; Silberstein EB.UI/PMID: 29475999.Digital Object Identifier: https://dx.doi.org/10.2967/jnumed.117.206219 (Click here)
57. Selected Radiation Safety Aspects including Transportation and Lodging after Outpatient <sup>131</sup>I Therapy for Differentiated Thyroid Cancer

by Gomes-Lima, Cristiane Jeyce; Wu, Di; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2017Citation: Thyroid. , 2017 Nov 13.Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Gomes-Lima CJ; Wu D; Kharazi PH; Khorjekar G; Ringel MD; Vetter RJ; Bloom G; Burman KD; Wartofsky L; Van Nostrand D.UI/PMID: 29132255.Digital Object Identifier: https://dx.doi.org/10.1089/thy.2017.0124 (Click here)
58. Radioiodine Theranostics: Increasing Dialogue and Collaboration

by Van Nostrand, Douglas.

Published: 2017Citation: Journal of Nuclear Medicine. 58(10):19N-20N, 2017 Oct.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Van Nostrand D.UI/PMID: 28970353.Online Access: Click here to access online
59. Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models

by Van Nostrand, Douglas; Burman, Kenneth D; Wartofsky, Leonard.

Published: 2017Citation: Endocrine Connections. , 2017 Aug 08.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine; Medicine/Endocrinology.Publication: Journal Article.Article type: Journal Article.Full author list: Klubo-Gwiezdzinska J; Costello J; Jensen K; Patel A; Tkavc R; Van Nostrand D; Burman K; Wartofsky L; Vasko V.UI/PMID: 28790138.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1530/EC-17-0138 (Click here)
60. Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer. [Review]

by Van Nostrand, Douglas.

Published: 2017Citation: Endocrinology & Metabolism Clinics of North America. 46(3):783-793, 2017 Sep.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Van Nostrand D.UI/PMID: 28760238.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.ecl.2017.04.007 (Click here)
61. Effects of Dosimetrically Guided I-131 Therapy on Hematopoiesis in Patients With Differentiated Thyroid Cancer

by Bikas, Athanasios; Schneider, Mark; Desale, Sameer; Atkins, Francis; Mete, Mihriye; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Published: 2016Citation: Journal of Clinical Endocrinology & Metabolism. 101(4):1762-9, 2016 Apr.Institution: MedStar Heart & Vascular Institute; MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Bikas A; Schneider M; Desale S; Atkins F; Mete M; Burman KD; Wartofsky L; Van Nostrand D.UI/PMID: 26900639.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1210/jc.2015-3544 (Click here)
62. Number of Foci of Functioning Thyroid Tissue Remaining after Thyroidectomy for Differentiated Thyroid Cancer: Institutional Experience

by Kulkarni, Kanchan; Khorjekar, Gauri; Mete, Mihriye; Van Nostrand, Douglas.

Published: 2017Citation: World Journal of Nuclear Medicine. 16(2):122-125, 2017 Apr-Jun.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Kulkarni K; Khorjekar G; Mete M; Van Nostrand D.UI/PMID: 28553178.Digital Object Identifier: https://dx.doi.org/10.4103/1450-1147.203066 (Click here)
63. Assessment of serial comprehensive metabolic panels following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer

by Bikas, Athanasios; Boulougoura, Afroditi; Mirza, Faryal; Vachhani, Shivangi; Wartofsky, Leonard; Van Nostrand, Douglas; Burman, Kenneth D.

Citation: Unpublished 2016/03/14.Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Bikas A, Boulougoura A, Mirza F, Vachhani S, Wartofsky L, Van Nostrand D, Burman K .Local accession number: 2016_51.
64. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer

by Atkins, Francis; Garcia, Carlos; Van Nostrand, Douglas.

Published: 2017Citation: Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Plyku D; Hobbs RF; Huang K; Atkins F; Garcia C; Sgouros G; Van Nostrand D.UI/PMID: 28104741.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.2967/jnumed.116.179366 (Click here)
65. Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer

by Bikas, Athanasios; Van Nostrand, Douglas; Desale, Sameer; Mete, Mihriye; Wartofsky, Leonard; Burman, Kenneth D.

Published: 2016Citation: Thyroid. 26(2):280-6, 2016 Feb.Institution: MedStar Washington Hospital Center; MedStar Heart & Vascular Institute; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Bikas A; Van Nostrand D; Jensen K; Desale S; Mete M; Patel A; Wartofsky L; Vasko V; Burman KD.UI/PMID: 26649977.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1089/thy.2015.0413 (Click here)
66. Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I

by Atkins, Francis; Van Nostrand, Douglas; Moreau, Shari; Burman, Kenneth D; Wartofsky, Leonard.

Published: 2015Citation: Thyroid. 25(12):1347-50, 2015 Dec..Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine; Medicine/Nuclear Medicine; Medicine/Nuclear Medicine; Medicine/Endocrinology; Medicine/Endocrinology.Publication: Journal Article.Article type: Journal Article; Research Support, Non-U.S. Gov't; Validation Studies.Full author list: Atkins F; Van Nostrand D; Moreau S; Burman K; Wartofsky L.UI/PMID: 26357962.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1089/thy.2014.0616 (Click here)
67. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer (DTC) - organ dosimetry

by Atkins, Francis; Van Nostrand, Douglas.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Plyku D, Hobbs FR, Srinivasan S, Atkins F, Van Nostrand D, Sgouros G.Local accession number: 2015_188.
68. How should one measure and how low should the urinary iodine excretion be prior to radioiodine imaging and/or therapy in patients with differentiated thyroid cancer? An educational exhibit

by Bethancourt, E; Moreau, Shari; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Bethancourt E, Moreau S, Guan H, Burman K, Wartofsky L, Van Nostrand D.Local accession number: 2015_189.
69. The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey

by Bethancourt, E; Van Nostrand, Douglas; Orquiza, Michael H; Bikas, A; Burman, Kenneth D; Wartofsky, Leonard.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l.Local accession number: 2015_190.
70. The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey

by Bethancourt, E; Van Nostrand, Douglas; Orquiza, Michael H; Bikas, A; Burman, Kenneth D; Wartofsky, Leonard.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l.Local accession number: 2015_191.
71. Assessment of serial complete blood counts following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer

by Bikas, A; Burman, Kenneth D; Desale, Sameer; Mete, Mihriye; Boyle, Lisa M; Wartofsky, Leonard; Van Nostrand, Douglas.

Citation: Unpublished 2015 Mar 9.Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Bikas A, Burman K, Desale S, Mete M, Boyle L, Wartofsky L, Van Nostrand D.Local accession number: 2015_75.
72. Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts

by Bikas, A; Burman, Kenneth D; Mete, Mihriye; Desale, Sameer; Wartofsky, Leonard; Van Nostrand, Douglas.

Citation: Unpublished 2015 Mar 5.Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Bikas A, Burman K, Desale S., Mete M, Wartofsky L, Van Nostrand D.Local accession number: 2015_207.
73. The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer

by Garcia, Carlos; Van Nostrand, Douglas; Wexler, Jason; Bethancourt, E; Burman, Kenneth D; Wartofsky, Leonard.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Garcia CA, Van Nostrand D, Wexler JA, Bethancourt E, Burman k, Wartofsky l.Local accession number: 2015_192.
74. 124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods

by Atkins, Francis; Garcia, Carlos; Van Nostrand, Douglas.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D.Local accession number: 2015_193.
75. Metformin attenuates 131I - induced decrease in peripheral blood cells in patients with differentiated thyroid cancer

by Bikas, A; Van Nostrand, Douglas; Desale, Sameer; Mete, Mihriye; Wartofsky, Leonard; Burman, Kenneth D.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K.Local accession number: 2015_194.
76. I-131 dosimetry for differentiated thyroid cancer

by Van Nostrand, Douglas.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Van Nostrand D.Local accession number: 2015_196.
77. The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review

by Van Nostrand, Douglas.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Van Nostrand D.Local accession number: 2015_197.
78. 124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods

by Atkins, Francis; Garcia, Carlos; Van Nostrand, Douglas.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D.Local accession number: 2015_193.
79. Metformin attenuates 131I - induced decrease in peripheral blood cells in patients with differentiated thyroid cancer

by Bikas, A; Van Nostrand, Douglas; Desale, Sameer; Mete, Mihriye; Wartofsky, Leonard; Burman, Kenneth D.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K.Local accession number: 2015_194.
80. I-131 dosimetry for differentiated thyroid cancer

by Van Nostrand, Douglas.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Van Nostrand D.Local accession number: 2015_196.
81. The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review

by Van Nostrand, Douglas.

Citation: Unpublished 2015 Jun 6.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Van Nostrand D.Local accession number: 2015_197.
82. Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts

by Bikas, A; Burman, Kenneth D; Desale, Sameer; Mete, Mihriye; Wartofsky, Leonard; Van Nostrand, Douglas.

Citation: Unpublished 2015 Mar 5.Institution: MedStar Heart & Vascular Institute; MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology.Publication: Conference Activity.Full author list: Bikas A, Burman K, Desale S, Mete M, Wartofsky L, Van Nostrand D.Local accession number: 2014.1_177.
83. Amifostine used clinically for salivary gland protection during therapy with radioiodine is cytotoxic for thyroid cancer cells

by Klubo-Gwiezdzinska, Joanna; Van Nostrand, Douglas; Burman, Kenneth D; Wartofsky, Leonard.

Citation: Unpublished 2014 May 6.Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Klubo-Gwiezdzinska J, Costello Jr J, Jensen K, Patel A, Van Nostrand D,Burman KD, Wartofsky L, Vasko V.Local accession number: 2014.1_2.
84. GU and thyroid cancer

by Van Nostrand, Douglas.

Citation: Unknown 2014 Jun 7.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Van Nostrand D.Local accession number: 2014.1_128.
85. Current use and controversies for I-131 in thyroid cancer

by Van Nostrand, Douglas.

Citation: Unknown 2014 Jun 7.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Van Nostrand D.Local accession number: 2014.1_129.
86. I-131 remnant ablation and adjuvant treatment: an interactive program

by Van Nostrand, Douglas.

Citation: Unknown 2014 Jun 7.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Van Nostrand D.Local accession number: 2014.1_130.
87. Survival rate in differentiated thyroid cancer patients with bone metastases

by Orquiza, Michael H; Van Nostrand, Douglas; Khorjekar, Gauri R; Moreau, Shari; Atkins, Francis; Kulkarni, Kanchan; Burman, Kenneth D; Wartofsky, Leonard.

Citation: Unknown 2014 Jun 7.Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/General Internal Medicine; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L.Local accession number: 2014.1_132.
88. Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration

by Orquiza, Michael H; Khorjekar, Gauri R; Schneider, M; Kulkarni, Kanchan; Garcia, Carlos; Acio, Elmo; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Citation: Unknown 2014 Jun 7.Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/General Internal Medicine; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D.Local accession number: 2014.1_133.
89. Altered taste after 131I therapy: the frequency, time of onset, severity, and duration

by Orquiza, Michael H; Khorjekar, Gauri R; Schneider, M; Kulkarni, Kanchan; Garcia, Carlos; Acio, Elmo; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Citation: Unknown 2014 Jun 7.Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/General Internal Medicine; Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D.Local accession number: 2014.1_134.
90. The use of diuretics for increasing radioiodine (RAI) uptake in patients with well-differentiated thyroid cancer

by Orquiza, Michael H; Van Nostrand, Douglas.

Citation: Unknown 2014 Jun 7.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Orquiza M, Van Nostrand D.Local accession number: 2014.1_135.
91. Detection of 131I in public places: a national survey

by Van Nostrand, Douglas; Orquiza, Michael H.

Citation: Unknown 2014 Jun 7.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Van Nostrand D,Orquiza M, Bloom G.Local accession number: 2014.1_131.
92. Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?

by Khorjekar, Gauri R; Van Nostrand, Douglas; Garcia, Carlos; O'Neil, Jeff; Moreau, Shari; Atkins, Francis; Mete, Mihriye; Orquiza, Michael H; Burman, Kenneth; Wartofsky, Leonard.

Citation: Thyroid. 24(9):1394-9, 2014 Sep..Institution: MedStar Health Research Institute; MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine; Medicine/Endocrinology.Publication: Journal Article.Article type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't.Full author list: Khorjekar GR; Van Nostrand D; Garcia C; O'Neil J; Moreau S; Atkins FB; Mete M; Orquiza MH; Burman K; Wartofsky L.UI/PMID: 24820222.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1089/thy.2013.0713 (Click here)
93. Current treatment modalities for spinal metastases secondary to thyroid carcinoma. [Review]

by Kushchayeva, Yevgeniya; Wexler, Jason; Carroll, Nancy M; Van Nostrand, Douglas; Burman, Kenneth D; Boyle, Lisa M.

Citation: Thyroid. 24(10):1443-55, 2014 Oct..Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Surgery/General Surgery; Medicine/Nuclear Medicine; Surgery.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Kushchayeva YS; Kushchayev SV; Wexler JA; Carroll NM; Preul MC; Teytelboym OM; Sonntag VK; Van Nostrand D; Burman KD; Boyle LM.UI/PMID: 24827757.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1089/thy.2013.0634 (Click here)
94. Spinal metastases due to thyroid carcinoma: an analysis of 202 patients

by Kushchayeva, Yevgeniya; Carroll, Nancy M; Felger, Erin A; Van Nostrand, Douglas; Burman, Kenneth D; Boyle, Lisa M.

Citation: Thyroid. 24(10):1488-500, 2014 Oct..Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Surgery/General Surgery; Surgery/Endocrine Surgery; Medicine/Nuclear Medicine; Medicine/Endocrinology; Surgery.Publication: Journal Article.Article type: Journal Article.Full author list: Kushchayeva YS; Kushchayev SV; Carroll NM; Felger EA; Links TP; Teytelboym OM; Bonichon F; Preul MC; Sonntag VK; Van Nostrand D; Burman KD; Boyle LM.UI/PMID: 24921429.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1089/thy.2013.0633 (Click here)
95. Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?

by Kulkarni, Kanchan; Van Nostrand, Douglas; Atkins, Francis; Mete, Mihriye; Wexler, Jason; Wartofsky, Leonard.

Citation: Nuclear Medicine Communications. 35(2):210-6, 2014 Feb..Publication: Journal Article.Article type: Clinical Trial; Comparative Study; Journal Article.Full author list: Kulkarni K; Van Nostrand D; Atkins F; Mete M; Wexler J; Wartofsky L.UI/PMID: 24177041.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1097/MNM.0000000000000034 (Click here)
96. 124I-NaI PET/CT based 3-D radiobiological Dosimetry (3D-RD) for 131I-NaI therapy of metastatic well-differentiated thyroid cancer

by Atkins, Frank; Khorjekar, Gauri; Orquiza, Michael D; Van Nostrand, Douglas; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Atkins F, Khorjekar G, Orquiza MD.Local accession number: 2013_232.
97. Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC)

by Khorjekar, Gauri; Orquiza, Michael D; Mete, Mihriye; Garcia, Carlos; Wartofsky, Leonard; Van Nostrand, Douglas; Atkins, Frank.

Institution: MedStar Washington Hospital Center; MedStar Health Research Institute; Washington Cancer Institute.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D.Local accession number: 2013_45.
98. Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC)

by Khorjekar, Gauri; Orquiza, Michael D; Atkins, Frank; Mete, Mihriye; Garcia, Carlos; Wartofsky, Leonard; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D.Local accession number: 2013_229.
99. Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer

by Khorjekar, Gauri; Orquiza, Michael D; Atkins, Frank; Mete, Mihriye; Garcia, Carlos; Wartofsky, Leonard; Van Nostrand, Douglas.

Citation: Journal of Nuclear Medicine 54(Suppl):52, 2013.Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D.Local accession number: 2013_163.
100. Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx)

by Orquiza, Michael D; Khorjekar, Gauri; Schneider, Mark; Kulkarni, Kanchan; Garcia, Carlos; Acio, Elmo; Burman, Kenneth D; Wartofsky, Leonard; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D.Local accession number: 2013_77.
101. Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with differentiated thyroid cancer with suspected bone metastases

by Orquiza, Michael D; Schneider, Mark; Garcia, Carlos; O'Neil, Jeffrey; Van Nostrand, Douglas; Wexler, Jason; Burman, Kenneth D; Wartofsky, Leonard.

Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L.Local accession number: 2013_80.
102. Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results

by Orquiza, Michael D; Hall, Jordan; Van Nostrand, Douglas; Khorjekar, Gauri; Mete, Mihriye.

Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G.Local accession number: 2013_75.
103. Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit

by Orquiza, Michael D; Van Nostrand, Douglas; Khorjekar, Gauri; Wartofsky, Leonard.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L.Local accession number: 2013_78.
104. The utility of "blind" 131I treatments for differentiated thyroid cancer (DTC): an educational exhibit

by Orquiza, Michael D; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza M, Elboga U, Zeki C, Aktolun C, Van Nostrand D.Local accession number: 2013_81.
105. Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit

by Orquiza, Michael D; Duong, Eric; Khorjekar, Gauri; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza M, Duong E, Khorjekar G, Van Nostrand D.Local accession number: 2013_74.
106. Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations

by Orquiza, Michael D; Van Nostrand, Douglas; Khorjekar, Gauri.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza M, Guan H, Van Nostrand D, Li Y, Teng W, Khorjekar G.Local accession number: 2013_79.
107. Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer with suspected bone metastases

by Orquiza, Michael D; Schneider, Mark; Garcia, Carlos; O'Neil, Jeffrey; Van Nostrand, Douglas; Wexler, Jason; Burman, Kenneth D; Wartofsky, Leonard.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L.Local accession number: 2013_210.
108. Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results

by Orquiza, Michael D; Hall, Jordan; Van Nostrand, Douglas; Khorjekar, Gauri; Mete, Mihriye.

Citation: Clinical Nuclear Medicine 38:488 (2013).Institution: MedStar Washington Hospital Center; .Department: Medicine/Nuclear Medicine.Publication: Conference Activity.Full author list: Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G.Local accession number: 2013_211.
109. Whole body retention of I-131 at 24hr vs. 48hr as a predictor of maximum tolerated activity (MTA)

by Atkins, Frank; Van Nostrand, Douglas; Orquiza, Michael D; Wartofsky, Leonard.

Institution: MedStar Washington Hospital Center.Department: Department of Medicine/Endocrinology; Department of Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Atkins F, Van Nostrand D, Orquiza M, Wartofsky L.Local accession number: 2013_158.
110. 124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer

by Atkins, Frank; Khorjekar, Gauri; Orquiza, Michael D; Van Nostrand, Douglas.

Citation: Journal of Nuclear Medicine 54(suppl):53, 2013.Institution: MedStar Washington Hospital Center.Department: Department of Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G.Local accession number: 2013_166.
111. #Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit

by Duong, Eric; Orquiza, Michael D; Khorjekar, Gauri; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Department of Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Duong E, Orquiza M, Khorjekar G, Van Nostrand D.Local accession number: 2013_159.
112. Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit

by Duong, Eric; Orquiza, Michael D; Khorjekar, Gauri; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Duong E, Orquiza M, Khorjekar G, Van Nostrand D.Local accession number: 2013_233.
113. The utility of "Blind" 131 I treatment for differentiated thyroid cancer: an educational exhibit

by Elboga, Umut; Orquiza, Michael D; Van Nostrand, Douglas.

Citation: Journal of Nuclear Medicine 54(Suppl):1290, 2013.Institution: MedStar Washington Hospital Center.Department: Department of Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D.Local accession number: 2013_160.
114. Whole body retention of 131I at 24hr versus 48hr as a predictor of maximum tolerated activity (MTA)

by Orquiza, Michael D; Van Nostrand, Douglas; Atkins, Frank; Wartofsky, Leonard.

Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Poster Presentation.Local accession number: 2013_231.
115. The Utility of "Blind" 131I treatments for differentiated thyroid cancer: an educational exhibit

by Orquiza, Michael D; Van Nostrand, Douglas.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D.Local accession number: 2013_234.
116. Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations

by Van Nostrand, Douglas; Orquiza, Michael D; Khorjekar, Gauri.

Citation: Journal of Nuclear Medicine 54(suppl):1288, 2013.Institution: MedStar Washington Hospital Center.Department: Department of Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G.Local accession number: 2013_161.
117. Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations

by Van Nostrand, Douglas; Orquiza, Michael D; Khorjekar, Gauri.

Citation: Journal of Nuclear Medicine 54(suppl):1289, 2013.Institution: MedStar Washington Hospital Center.Department: Department of Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G.Local accession number: 2013_162.
118. Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations

by Van Nostrand, Douglas; Orquiza, Michael D; Khorjekar, Gauri.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G.Local accession number: 2013_235.
119. Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations

by Van Nostrand, Douglas; Orquiza, Michael D; Khorjekar, Gauri.

Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Poster Presentation.Full author list: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G.Local accession number: 2013_236.
120. Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer. [Review]

by Burman, Kenneth D; Klubo-Gwiezdzinska, Joanna; Mete, Mihriye; Van Nostrand, Douglas; Wartofsky, Leonard.

Citation: Endocrine Practice. 19(1):139-48, 2013 Jan-Feb..Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Burman KD; Jonklaas J; Klubo-Gwiezdzinska J; Mete M; Van Nostrand D; Wartofsky L.UI/PMID: 23186979.Digital Object Identifier: http://dx.doi.org/10.4158/EP12244.RA (Click here)
121. Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin

by Klubo-Gwiezdzinska, Joanna; Burman, Kenneth D; Van Nostrand, Douglas; Mete, Mihriye; Wartofsky, Leonard.

Citation: Thyroid. 22(3):310-7, 2012 Mar..Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Comparative Study; Journal Article.Full author list: Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Mete M; Jonklaas J; Wartofsky L.UI/PMID: 22313411.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1089/thy.2011.0235 (Click here)
122. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.[Erratum appears in J Nucl Med. 2012 May;53(5):830]

by Van Nostrand, Douglas; Khorjekar, Gauri R; O'Neil, Jeff; Moreau, Shari; Atkins, Frank B; Kharazi, Pejman; Mete, Mihriye; Chennupati, Shyam P; Burman, Kenneth D; Wartofsky, Leonard.

Citation: Journal of Nuclear Medicine. 53(3):359-62, 2012 Mar..Institution: MedStar Washington Hospital Center; MedStar Health Research Institute.Department: Medicine/Nuclear Medicine; Medicine/Endocrinology.Publication: Journal Article.Article type: Journal Article; Research Support, Non-U.S. Gov't.Full author list: Van Nostrand D; Khorjekar GR; O'Neil J; Moreau S; Atkins FB; Kharazi P; Mete M; Chennupati SP; Burman KD; Wartofsky L.UI/PMID: 22315442.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.111.096016 (Click here)
123. Controversies, Consensus and Collaboration in the Use of I-131 Therapy in Differentiated Thyroid Cancer

by Van Nostrand, Douglas.

Published: ; 2019Citation: Thyroid. 2019 Mar 22.Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Tuttle RM MD; Ahuja S; Avram AM; Bernet V; Bourguet P; Daniels GH; Dillehay G; Draganescu C; Giovanella L; Flux G; Fuehrer D; Greenspan B; Luster M; Muylle K; Smit J; Van Nostrand D; Verburg F; Hegedus L.UI/PMID: 30900516.Digital Object Identifier: https://dx.doi.org/10.1089/thy.2018.0597 (Click here)
124. Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen

by Klubo-Gwiezdzinska, Joanna; Burman, Kenneth D; Van Nostrand, Douglas; Wartofsky, Leonard.

Published: ; 2011Citation: Journal of Thyroid Research. 2011:843591, 2011..Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology; Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Wartofsky L.UI/PMID: 21876837.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.4061/2011/843591 (Click here)

Powered by Koha